IL-6, a well-established cytokine induced by IL-1β in intestinal epithelial cells (IECs) [55], has been shown to promote tumor progression in CAC through the activation of the oncogene STAT3 [56] in addition to IL-11 [57]. The gene discussed is STAT3; the disease is neoplasm.